Abstract:Emily OC Palmer, 1 Sheryl Ker, 2 Miguel E Rentería, 3 Thomas Carmody, 4 A John Rush 5, 6 1 Holmusk Europe Ltd, London, UK; 2 KKT Technologies, Pte. Ltd, Singapore; 3 QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; 4 Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA; 5 Duke University School of Medicine, Duke University School of Medicine, Durham, NC, USA; 6 Clinical sciences, Duke-National University of Singapore, Singapore Correspondence: Emily OC Palmer, Holmusk Europe Ltd, 414 Linen Hall, 162-168 Regent St, London, W1B 5TE, UK, Email Purpose: Major depressive disorder (MDD) is a leading cause of disability worldwide. An accurate assessment of depressive symptomology is crucial for clinical management and research. This study assessed the convergent validity, reliability, and total scale score interconversion across the 9-item Patient Health Questionnaire (PHQ-9) self-report, the 16-item Quick Inventory of Depressive Symptomatology-clinician report (QIDS-C) (two widely used clinical ratings) and the 5-item Very Brief Quick Inventory of Depressive Symptoms-clinician report (VQIDS-C), which evaluate the core features of MDD. Patients and Methods: This study leveraged electronic health record (EHR)-derived, de-identified data from the NeuroBlu Database (Version 23R1), a longitudinal behavioural health real-world platform. Classical Test Theory (CTT) and Item Response Theory (IRT) analyses were used to evaluate the reliability, validity of, and conversions between the scales. The Test Information Function (TIF) was calculated for each scale, with greater test information reflecting higher precision and reliability in measuring depressive symptomology. IRT was also used to generate conversion tables so that total scores on each scale could be compared to the other. Results: The study sample (n = 2,156) had an average age of 36.4 years (standard deviation [SD] = 13.0) and 59.7% were female. The mean depression scores for the PHQ-9, QIDS-C, and VQIDS-C were 12.9 (SD = 6.6), 12.0 (SD = 4.9), and 6.18 (SD = 3.2), respectively. The Cronbach's alpha coefficients for PHQ-9, QIDS-C, and VQIDS-C were 0.9, 0.8, and 0.7, respectively, suggesting acceptable internal consistency. PHQ-9 (TIF = 30.3) demonstrated the best assessment of depressive symptomology, followed by QIDS-C (TIF = 25.8) and VQIDS-C (TIF = 17.7). Conclusion: Overall, PHQ-9, QIDS-C, and VQIDS-C appear to be reliable and convertible measures of MDD symptomology within a US-based adult population in a real-world clinical setting. Keywords: psychometrics, linking, patient health questionnaire, quick inventory of depressive symptoms, depression, real-world data Major depressive disorder (MDD) is a leading cause of disability worldwide, with an estimated lifetime prevalence in the United States (US) of 20%. 1 Accurate and reliable assessment of MDD is crucial for effective treatment and management. The Patient Health Questionnaire-9 (PHQ-9; self-report) and the clinician rated Quick Inventory of Depressive Symptomatology (QIDS-C) 2 are widely used and validated tools to assess the prevalence and severity of depressive symptoms in patients with MDD. These scales are used both in clinical research and practice. The PHQ-9 assesses the prevalence over the past two weeks of the nine criterion depressive symptom domains that define a major depressive episode based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 3 It is a self-administered questionnaire that can be completed in a few minutes, making it a convenient tool for clinicians and patients. The PHQ-9 has demonstrated good psychometric properties in various populations, including adults 4,5 and adolescents, 6 and has been translated into multiple languages. 7–13 The QIDS-C consists of 16 items that cover the same nine DSM-5 criterion symptom domains; it has clinician report and self-report versions. 2,14 The QIDS-C has demonstrated good psychometric properties, including high internal consistency, test-retest reliability, and strong convergent validity with other depression measures. 15 In recent years, the 5-item Very Quick Inventory of Depressive Symptomatology (VQIDS-C) 16 was developed as a more convenient method for rapid clinical assessment and is effective at evaluating the core features of depression. The self-report version of the QIDS and PHQ-9 have been compared in Asian primary care settings and shown good internal consistency. 17 However, these measures have not been evaluated together in a lar -Abstract Truncated-

Should an assessment of Axis I comorbidity be included in the initial diagnostic assessment of mood disorders? Role of QIDS-16-SR total score in predicting number of Axis I comorbidity

Screening for Bipolar Disorder with the Mood Disorders Questionnaire in Patients Diagnosed As Major Depressive Disorder — the Experience in China

Evaluation of Mood Disorder Questionnaire (MDQ) in Patients with Mood Disorders: a Multicenter Trial Across China.

Hypomanic Symptoms Assessed by the HCL-32 in Patients with Major Depressive Disorder: a Multicenter Trial Across China.

Axis Ⅰ comorbidity of the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders among heroin-dependent patients

Psychometric evaluation and linking of the PHQ-9, QIDS-C, and VQIDS-C in a real-world population with major depressive disorder

Factors associated with false positives in MDQ screening for bipolar disorder: Insight into the construct validity of the scale

Preliminary utility of Mood Disorder Questionnaire to screen bipolar disorder in depressive patients

Comorbidity between bipolar disorder and cluster B personality disorders as indicator of affective dysregulation and clinical severity

Co-Morbidity of DSM-IV Personality Disorder in Major Depressive Disorder among Psychiatric Outpatients in China: A Further Analysis of an Epidemiologic Survey in a Clinical Population

Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample.

Assessing the Quick Inventory of Depressive Symptomatology Self-Report scores to predict continuous employment in mood disorder patients

ICD-11 'mixed depressive and anxiety disorder' is clinical rather than sub-clinical and more common than anxiety and depression in the general population

Borderline Personality Disorder With Depression Confers Significant Risk of Suicidal Behavior in Mood Disorder Patients—A Comparative Study

Comorbid attention-deficit/hyperactivity disorder in adult psychiatric outpatients with depressive or anxiety disorders

A survey of the comorbidity of borderline personality disorder among psychiatric outpatients at Shanghai Mental Health Center

Comorbidity Analysis among Heroin Dependent Patients

Depression prevalence using the HADS-D compared to SCID major depression classification: An individual participant data meta-analysis

Associations Between Cognitive Symptoms and Functional Outcomes in Chinese Patients with Depression in a 6-Month Non-Interventional, Prospective Study

Prevalence and clinical correlates of benzodiazepine use in the patients with major depressive disorder

[Psychiatric comorbidities in patients referred for irritable bowel syndrome].